Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Tisato, Veronica ^a   Zauli, Giorgio ^b   Voltan, Rebecca ^a   Gianesini, Sergio ^a   Iasio, Maria Grazia ^a   Volpi, Ilaria ^a   Fiorentini, Guido ^a   Zamboni, Paolo ^a   Secchiero, Paola ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD146 ANTIGEN; CD31 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; OSTEOPROTEGERIN; VASCULOTROPIN;

ADULT; ARTICLE; CARDIAC PATIENT; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC VEIN INSUFFICIENCY; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PHENOTYPE; PROTEIN EXPRESSION; SAPHENOUS VEIN; STARVATION; TRANSCRIPTION INITIATION;

ADULT; ANTIGENS, CD146; ANTIGENS, CD31; BODY MASS INDEX; CELL CULTURE TECHNIQUES; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; KINETICS; MALE; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; PHENOTYPE; SAPHENOUS VEIN; VASCULAR DISEASES;

EID: 84862682982     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039543     Document Type: Article

References (38)

1. Eberhardt RT, Raffetto JD, (2005) Chronic venous insufficiency. Circulation 111: 2398-2409.
2. Parkington HC, Coleman HA, Tare M, (2004) Prostacyclin and endothelium dependent hyperpolarization. Pharmacol Res 49: 509-514.
3. Levi M, Keller TT, van Gorp E, ten Cate H, (2003) Infection and inflammation and the coagulation system. Cardiovasc Res 60: 26-39.
4. von Andrian UH, Mackay CR, (2000) T-Cell function and migration. Two sides of the same coin. N Engl J Med 343: 1020-1034.
5. Ulbrich H, Eriksson EE, Lindbom L, (2003) Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharmacol Sci 24: 640-647.
6. Lusis AJ, (2000) Atherosclerosis. Nature 407: 233-241.
7. Eriksson EE, (2003) Leukocyte recruitment to atherosclerotic lesions, a complex web of dynamic cellular and molecular interactions. Curr Drug Targets Cardiovasc Haematol Disord 3: 309-325.
8. Wakefield TW, Strieter RM, Prince MR, Downing LJ, Greenfield LJ, (1997) Pathogenesis of venous thrombosis: a new insight. Cardiovasc Surg 5: 6-15.
9. Gimbrone MA Jr, Topper JN, Nagel T, Anderson KR, Garcia-Cardena G, (2000) Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci 902: 230-239.
10. Ley K, (2002) Integration of inflammatory signals by rolling neutrophils. Immunol Rev 186: 8-18.
11. Sumpio BE, Riley JT, Dardik A, (2002) Cells in focus: endothelial cell. Int J Biochem Cell Biol 34: 1508-1512.
12. Lawson ND, Weinstein BM, (2002) Arteries and veins: making a difference with zebrafish. Nat Rev Genet 3: 674-682.
13. Eriksson EE, Karlof E, Ludmark K, Rotzius P, Hedin U, et al. (2005) Powerful inflammatory properties of large vein endothelium in vivo. Arterioscler Thromb Vasc Biol 25: 723-728.
14. Schmid-Schonbein GW, Takase S, Bergan JJ, (2001) New advances in the understanding of the pathophysiology of chronic venous insufficiency. Angiology 52: S27-S34.
15. Zauli G, Melloni E, Capitani S, Secchiero P, (2009) Role of full-length osteoprotegerin in tumor cell biology. Cell Mol Life Sci 66: 841-851.
16. Zauli G, Corallini F, Bossi F, Fischietti F, Durigotto P, et al. (2007) Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo. Blood 110: 536-543.
17. Campioni D, Corallini A, Zauli G, Possati L, Altavilla G, et al. (1995) HIV type 1 extracellular tat protein stimulates growth and protects cells of BK virus/tat transgenic mice from apoptosis. AIDS Res Hu Retrov 11: 1039-1048.
18. Secchiero P, Zerbinati C, di Iasio MG, Melloni E, Tiribelli M, et al. (2007) Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells. Curr Drug Metab 8: 395-403.
19. Voltan R, di Iasio MG, Bosco R, Valeri N, Pekarski Y, et al. (2011) Nutlin-3 downregulates the expression of the oncogene TCL1 in primary B chronic lymphocytic leukemic cells. Clin Cancer Res 17: 5649-5655.
20. Secchiero P, Corallini F, Beltrami AP, Ceconi C, Bonasia V, et al. (2010) An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction. Atherosclerosis 210: 274-277.
21. Malyankar UM, Scatena M, Suchland KL, Yun TJ, Clark EA, et al. (2000) Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells. J Biol Chem 275: 20959-20962.
22. Leychenko A, Konorev E, Jijma M, Matter ML, (2011) Strech-induced hypertrophy activates NF-kB-mediated VEGF secretion in adult cardiomyocytes. PloS One 6: e29055.
23. Bardin N, Blot-Chabaud M, Despoix N, Kebir A, Harhouri K, et al. (2009) CD146 and its soluble form regulate monocyte transendothelial migration. Arterioscler Thromb Vasc Biol 29: 746-753.
24. Harhouri K, Kebir A, Guillet B, Foucault-Bertaud A, Voytenko S, et al. (2010) Soluble CD146 displays angiogenic properties and promotes neovascularization in experimental hind-limb ischemia. Blood 115: 3843-3851.
25. Glen K, Luu NT, Ross E, Buckley CD, Rainger GE, et al. (2012) Modulation of functional responses of endothelial cells linked to angiogenesis and inflammation by shear stress: differential effects of the mechanotransducer CD31. J Cell Physiol 227: 2710-2721.
26. Privratsky JR, Newman DK, Newman PJ, (2010) PECAM-1: conflicts of interest in inflammation. Life Sci 87: 69-82.
27. Lawson C, Wolf S, (2009) ICAM-1 signaling in endothelial cells. Pharmacol Rep 61: 22-32.
28. Alcaide P, Maganto-Garcia E, Newton G, Travers R, Croce KJ, et al. (2012) Difference in Th1 and Th17 lymphocyte adhesion to endothelium. J Immunol 188: 1421-1430.
29. Beidler SK, Douillet CD, Berndt DF, Keagy BA, Rich PB, et al. (2009) Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy. J Vasc Surg 49: 1013-1020.
30. Carrasco OF, Ranero A, Hong E, Vidrio H, (2010) Endothelial function impairment in chronic venous insufficiency: effect of some cardiovascular protectant agents. Angiology 60: 763-771.
31. Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, et al. (2003) An association between atherosclerosis and venous thrombosis. N Engl J Med 348: 1435-1441.
32. Hong C, Zhu F, Du D, Pilgram TK, Sicard GA, et al. (2005) Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism. Atherosclerosis 183: 168-184.
33. Auzky O, Lanska V, Pitha J, Roztocil K, (2011) Association between symptoms of chronic venous disease in the lower extremities and cardiovascular risk factors in middle-aged women. Int Angiol 30: 335-341.
34. Venuraju SM, Yerramasu A, Corder R, Lahiri A, (2010) Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. J Am Coll Cardiol 55: 2049-2061.
35. Vik A, Mathiesen EB, Brox J, Wilsgaard T, Njølstad I, et al. (2011) Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø Study. J Thromb Haemost 9: 638-644.
36. Mogelvang R, Pedersen SH, Flyvbjerg A, Bjerre M, Iversen AZ, et al. (2012) Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis. Am J Cardiol 109: 515-520.
37. Westra J, de Groot L, Plaxton SL, Brouwer E, Posthumus MD, et al. (2011) Angiopoietin-2 is highly correlated with inflammation and disease activity in recent-onset rheumatoid arthritis and could be predictive for cardiovascular disease. Rheumatology 50: 665-673.
38. Naskret D, Zozulinska-Ziolkiewicz DA, Dankowski R, Wysocki H, Wierusz-Wysocka B, (2010) Albuminuria and VEGF as early markers of cardiovascular disturbances in young type 1 diabetic patients. Microvasc Res 80: 440-444.